Piper Sandler Maintains Neutral on Dentsply Sirona, Raises Price Target to $35
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Jason Bednar has maintained a Neutral rating on Dentsply Sirona (NASDAQ:XRAY) and increased the price target from $31 to $35.
January 12, 2024 | 4:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler has maintained a Neutral rating on Dentsply Sirona but raised the price target from $31 to $35, indicating a positive outlook on the stock's value.
The increase in price target by Piper Sandler suggests a more optimistic valuation of Dentsply Sirona's stock, which could lead to positive investor sentiment and a potential short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100